<DOC>
	<DOCNO>NCT00884260</DOCNO>
	<brief_summary>The purpose study ass efficacy , safety , bleed pattern low dose LNG ( 12 mg/ 24 hr ) , deliver locally new intrauterine contraceptive system suitable use woman 18 40 year age . In addition , pharmacokinetic assessment perform .</brief_summary>
	<brief_title>GA Levonorgestrel Intrauterine Contraceptive System ( LCS ) Phase III Study China</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Has , opinion investigator , suitable general uterine condition insert LCS . Normal cervical smear ( normal cervical smear within last six month prior visit 1 present writing accept . The cervical smear analyze report accord Bethesda System . ) Has clinically normal safety laboratory result ( i.e. , inside specify range inclusion ) . Has regular menstrual cycle ( length cycle 2135 day ) ( i.e. , endogenous cyclicity without hormonal contraceptive use ) . Known suspected pregnancy lactate . Vaginal delivery , cesarean delivery , abortion within 6 week prior visit 2 . Note : Postpartum insertion postpone uterus fully involuted , however earlier 6 week delivery . If involution substantially delay , consider wait 12 week postpartum . In case difficult insertion and/or exceptional pain bleed insertion , physical examination ultrasound perform immediately exclude perforation . History ectopic pregnancy . Note : For Korea : History ectopic pregnancy high probability ectopic gestation . Infected abortion within 3 month prior visit 1 . Note : For Korea : Endometritis delivery infect abortion within 3 month prior visit 1 . Abnormal uterine bleed unknown origin . Any genital infection ( successfully treat ) . History , current , pelvic inflammatory disease Congenital acquire uterine anomaly . Any distortion uterine cavity ( e.g. , fibroid ) likely cause problem ( opinion investigator ) insertion , retention removal LCS . History , diagnose suspect genital malignancy , untreated cervical dysplasia . Current deep venous thrombosis thrombophlebitis ; history deep venous thrombosis . Clinically significant endometrial polyp ( ) , , opinion investigator , interfere assessment bleed profile study Clinically significant ovarian cyst ( ) Use longacting injectable sexhormone preparation within 12 month prior start study medication , enter subset : sexhormone administration within one month prior start study medication .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Intrauterine contraception system</keyword>
</DOC>